Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May-Jun;55(3):282-6.
doi: 10.1097/MAT.0b013e3181909d76.

In vitro characterization and performance testing of the ension pediatric cardiopulmonary assist system

Affiliations

In vitro characterization and performance testing of the ension pediatric cardiopulmonary assist system

George M Pantalos et al. ASAIO J. 2009 May-Jun.

Abstract

In the last 40 years, mechanical circulatory support devices have become an effective option for the treatment of end-stage heart failure in adults. Few possibilities, however, are available for pediatric cardiopulmonary support. Ension Inc. (Pittsburgh, PA) is developing a pediatric cardiopulmonary assist system (pCAS) intended to address the limitations of existing devices used for this patient population. The pCAS device is an integrated unit containing an oxygenator and pump within a single casing, significantly reducing the size and blood-contacting surface area in comparison to current devices. Prototype pCAS devices produce appropriate flows and pressures while minimizing priming volume and preparation time. The pCAS was tested on a mock circulation designed to approximate the hemodynamic parameters of a small infant using a 10-Fr. extracorporeal membrane oxygenation inflow cannula and an 8-Fr. extracorporeal membrane oxygenation outflow cannula. Revision 4 of the device provided a flow rate of 0.42 L/min at 6,500 RPM. Revision 5, featuring improved impeller and diffuser designs, provided a flow rate of 0.57 L/min at 5,000 RPM. The performance tests indicate that for this cannulae combination, the pCAS pump is capable of delivering sufficient flows for patients <5 kg.

PubMed Disclaimer

Figures

Figure 1
Figure 1
pCAS cross-section.
Figure 2
Figure 2
Schematic representation of the mock loop system during cardiopulmonary assist.
Figure 3
Figure 3
Results of the Revision 4 pCAS. Top: Flow rates produced by pump as RPMs are incrementally increased. Middle: Change in pressure drop (ΔP) across the pump as the RPMs are incrementally increased. Bottom: Change in inlet and outlet pressure as a function of pCAS flow.
Figure 4
Figure 4
Results of Revision 5 pCAS. Top: Flow rates produced by pump as RPMs are incrementally increased. Middle: Change in pressure drop (ΔP) across the pump as the RPMs are incrementally increased. Bottom: Change in inlet and outlet pressure as a function of pCAS flow.
Figure 5
Figure 5
Comparison of flow rates between Revision 4 and Revision 5 as a function of RPM.

Similar articles

Cited by

References

    1. Rose, et al. Long term use of Left Ventricular Assist Device for End Stage Heart Failure. New England Journal of Medicine. 2001;345(20):1435–1443. - PubMed
    1. Baldwin JT, Borovetz HS, Duncan VW, Gartner MJ, Jarvik RK, Weiss WJ, Hoke TR. The National Heart Lung and Blood Institute Pediatric Ciruclatory Support Program. Circulation. 2006;113:147–155. - PubMed
    1. Spencer FC, Eisemen B, Trinkle JK, Rossi NP. Assisted Circulation for Cardiac Failure Following Intracardiac Surgery with Cardiopulmonary Bypass. JThoracic.Cardiovasc.Surg. 1965;49:56–73. - PubMed
    1. Cooper DS, Jacobs JP, Moore L, Stock A, Gaynor JW, Chancy T, Parpard M, Griffin DA, Owens T, Checchia PA, Thiagarajan RR, Spray TL, Ravishankar C. Cardiac Extraorpreal Life Support: State of the Art in 2007. Cardiol Young. 2007;17:104–115. - PubMed
    1. Tamblyn J. 5-13-2003. Ref Type: Personal Communication.

Publication types